These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36872523)

  • 1. Visual atrophy rating scales and amyloid PET status in an Alzheimer's disease clinical cohort.
    Loreto F; Gontsarova A; Scott G; Patel N; Win Z; Carswell C; Perry R; Malhotra P
    Ann Clin Transl Neurol; 2023 Apr; 10(4):619-631. PubMed ID: 36872523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of age-specific cut-offs for visual rating of medial temporal atrophy in classifying Alzheimer's disease, MCI and cognitively normal elderly subjects.
    Duara R; Loewenstein DA; Shen Q; Barker W; Varon D; Greig MT; Curiel R; Agron J; Santos I; Potter H
    Front Aging Neurosci; 2013; 5():47. PubMed ID: 24065917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and clinical correlation of practical cut-offs for visual rating scales of atrophy: normal aging versus mild cognitive impairment and Alzheimer's disease.
    Vanhoenacker AS; Sneyers B; De Keyzer F; Heye S; Demaerel P
    Acta Neurol Belg; 2017 Sep; 117(3):661-669. PubMed ID: 28397182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer's disease in a Chinese population.
    Wei M; Shi J; Ni J; Zhang X; Li T; Chen Z; Zhou M; Zhang L; Tan Z; Wang Y; Tian J
    BMC Geriatr; 2019 Feb; 19(1):59. PubMed ID: 30819102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease.
    Shen Q; Loewenstein DA; Potter E; Zhao W; Appel J; Greig MT; Raj A; Acevedo A; Schofield E; Barker W; Wu Y; Potter H; Duara R
    Alzheimers Dement; 2011 Jul; 7(4):e101-8. PubMed ID: 21784342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting amyloid-PET status in a memory clinic: The role of the novel antero-posterior index and visual rating scales.
    Zilioli A; Misirocchi F; Pancaldi B; Mutti C; Ganazzoli C; Morelli N; Pellegrini FF; Messa G; Scarlattei M; Mohanty R; Ruffini L; Westman E; Spallazzi M
    J Neurol Sci; 2023 Dec; 455():122806. PubMed ID: 38006829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment.
    Ferreira D; Cavallin L; Larsson EM; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Simmons A; Wahlund LO; Westman E;
    J Intern Med; 2015 Sep; 278(3):277-90. PubMed ID: 25752192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining Visual Rating Scales for Medial Temporal Lobe Atrophy and Posterior Atrophy to Identify Amnestic Mild Cognitive Impairment from Cognitively Normal Older Adults: Evidence Based on Two Cohorts.
    Sheng C; Sun Y; Wang M; Wang X; Liu Y; Pang D; Liu J; Bi X; Du W; Zhao M; Li Y; Li X; Jiang J; Han Y
    J Alzheimers Dis; 2020; 77(1):323-337. PubMed ID: 32716355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease.
    Ingala S; van Maurik IS; Altomare D; Wurm R; Dicks E; van Schijndel RA; Zwan M; Bouwman F; Schoonenboom N; Boelaarts L; Roks G; van Marum R; van Harten B; van Uden I; Claus J; Wottschel V; Vrenken H; Wattjes MP; van der Flier WM; Barkhof F
    Eur Radiol; 2022 Nov; 32(11):7789-7799. PubMed ID: 35639148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease.
    Smits LL; Tijms BM; Benedictus MR; Koedam EL; Koene T; Reuling IE; Barkhof F; Scheltens P; Pijnenburg YA; Wattjes MP; van der Flier WM
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S299-305. PubMed ID: 24210526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease.
    Lehmann M; Koedam EL; Barnes J; Bartlett JW; Ryan NS; Pijnenburg YA; Barkhof F; Wattjes MP; Scheltens P; Fox NC
    Neurobiol Aging; 2012 Mar; 33(3):627.e1-627.e12. PubMed ID: 21596458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment.
    Pyun JM; Park YH; Kim HR; Suh J; Kang MJ; Kim BJ; Youn YC; Jang JW; Kim S;
    Alzheimers Res Ther; 2017 Dec; 9(1):99. PubMed ID: 29246250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards validation in clinical routine: a comparative analysis of visual MTA ratings versus the automated ratio between inferior lateral ventricle and hippocampal volumes in Alzheimer's disease diagnosis.
    Wittens MMJ; Allemeersch GJ; Sima DM; Vanderhasselt T; Raeymaeckers S; Fransen E; Smeets D; de Mey J; Bjerke M; Engelborghs S
    Neuroradiology; 2024 Apr; 66(4):487-506. PubMed ID: 38240767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining visual rating scales to identify prodromal Alzheimer's disease and Alzheimer's disease dementia in a population from a low and middle-income country.
    Custodio N; Malaga M; Chambergo-Michilot D; Montesinos R; Moron E; Vences MA; Huilca JC; Lira D; Failoc-Rojas VE; Diaz MM
    Front Neurol; 2022; 13():962192. PubMed ID: 36119675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of MR Visual Rating Scales in Major Forms of Dementia.
    Kaushik S; Vani K; Chumber S; Anand KS; Dhamija RK
    J Neurosci Rural Pract; 2021 Jan; 12(1):16-23. PubMed ID: 33531755
    [No Abstract]   [Full Text] [Related]  

  • 16. Regional MRI volumetry using NeuroQuant versus visual rating scales in patients with cognitive impairment and dementia.
    Persson K; Barca ML; Edwin TH; Cavallin-Eklund L; Tangen GG; Rhodius-Meester HFM; Selbæk G; Knapskog AB; Engedal K
    Brain Behav; 2024 Feb; 14(2):e3397. PubMed ID: 38600026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic population.
    Claus JJ; Staekenborg SS; Holl DC; Roorda JJ; Schuur J; Koster P; Tielkes CEM; Scheltens P
    Eur Radiol; 2017 Aug; 27(8):3147-3155. PubMed ID: 28083697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal atrophy has limited usefulness as a diagnostic biomarker on the early onset Alzheimer's disease patients: A comparison between visual and quantitative assessment.
    Falgàs N; Sánchez-Valle R; Bargalló N; Balasa M; Fernández-Villullas G; Bosch B; Olives J; Tort-Merino A; Antonell A; Muñoz-García C; León M; Grau O; Castellví M; Coll-Padrós N; Rami L; Redolfi A; Lladó A
    Neuroimage Clin; 2019; 23():101927. PubMed ID: 31491836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does posterior cortical atrophy on MRI discriminate between Alzheimer's disease, dementia with Lewy bodies, and normal aging?
    O'Donovan J; Watson R; Colloby SJ; Firbank MJ; Burton EJ; Barber R; Blamire AM; O'Brien JT
    Int Psychogeriatr; 2013 Jan; 25(1):111-9. PubMed ID: 22809815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.